Stoke Therapeutics (STOK) Insider Trading & Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free STOK Stock Alerts $11.65 -0.07 (-0.60%) (As of 04/18/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Stoke Therapeutics (NASDAQ:STOK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$42.89 M Get STOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address STOK Insider Buying and Selling by Quarter Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Stoke Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/17/2024Skorpios TrustMajor ShareholderSell3,600,000$11.60$41,760,000.00 3/28/2024Jonathan AllanGeneral CounselSell5,126$13.20$67,663.20 3/19/2024Edward M Md KayeCEOSell11,150$6.10$68,015.00 3/19/2024Jonathan AllanGeneral CounselSell2,349$6.10$14,328.90 3/19/2024Stephen J TulipanoCFOSell4,116$6.10$25,107.60 2/1/2024Barry TichoInsiderSell10,000$4.80$48,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/2/2024Barry TichoInsiderSell10,000$5.74$57,400.00 7/3/2023Barry TichoInsiderSell15,000$10.60$159,000.00 6/21/2023Jonathan AllanGeneral CounselSell1,948$13.48$26,259.04 6/1/2023Barry TichoInsiderSell15,000$11.13$166,950.00 5/3/2023Barry TichoInsiderSell24,697$10.14$250,427.58 5/1/2023Barry TichoInsiderSell24,967$10.00$249,670.00 (Data available from 1/1/2013 forward) STOK Insider Trading Activity - Frequently Asked Questions Who is on Stoke Therapeutics's Insider Roster? The list of insiders at Stoke Therapeutics includes Barry Ticho, Edward M Md Kaye, Huw M Nash, Jonathan Allan, Skorpios Trust, and Stephen J Tulipano. Learn more on insiders at STOK. What percentage of Stoke Therapeutics stock is owned by insiders? 12.30% of Stoke Therapeutics stock is owned by insiders. Learn more on STOK's insider holdings. Which Stoke Therapeutics insiders have been selling company stock? The following insiders have sold STOK shares in the last 24 months: Barry Ticho ($1,028,652.28), Edward M Md Kaye ($68,015.00), Jonathan Allan ($108,251.14), Skorpios Trust ($41,760,000.00), and Stephen J Tulipano ($25,107.60). How much insider selling is happening at Stoke Therapeutics? Insiders have sold a total of 3,734,055 Stoke Therapeutics shares in the last 24 months for a total of $42,990,026.02 sold. More Insider Trading Tools from MarketBeat Related Companies: ALT Insider Trades CMPS Insider Trades APLT Insider Trades SLRN Insider Trades AVBP Insider Trades ANAB Insider Trades YMAB Insider Trades ALXO Insider Trades ANNX Insider Trades ATXS Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:STOK) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.